Complete and Accurate Records. Franchisee shall keep complete and accurate books of account and records of its business and operations under and in connection with this Agreement.
Complete and Accurate Records. University maintain records of the status and progress of the Research as required by the applicable Project Proposal with sufficient detail for use in reports to regulatory agencies.
Complete and Accurate Records. The information set forth in the books and records of the Business, which have been made available to the Purchasers, is correct and complete in all material respects and have been maintained, in all material respects, in accordance with sound business practices.
Complete and Accurate Records. [NAVY COLLABORATOR] PI shall maintain complete and accurate records of the status and progress of the Cooperative Work and shall provide such information to [NON-NAVY COLLABORATOR] upon request. [NAVY COLLABORATOR] PI shall promptly complete, and allow [NON-NAVY COLLABORATOR] access to, [NON-NAVY COLLABORATOR]-supplied case report forms for all Study Patients. Upon [NON-NAVY COLLABORATOR]’s request, [NAVY COLLABORATOR] PI shall correct any case report form errors and/or omissions by promptly submitting [NON-NAVY COLLABORATOR]-supplied forms for resolving document discrepancies. At all times [NON-NAVY COLLABORATOR] shall remain the sole owner of the case report forms and document discrepancy resolution forms.
Complete and Accurate Records. Provider shall, and shall cause Principal Investigator and each Study Staff Member to, prepare, maintain and retain complete, current, accurate, organized and legible Study Data (as defined below) as required by the Protocol and in a manner acceptable for the collection of data for submission to, or review by, any national, supranational or other governmental body having legal authority with respect to the Drug (each, a “Regulatory Authority”), including the US Food and Drug Administration or any successor agency thereto (“FDA”), and in full compliance with the Protocol and Law. “Study Data” means all laboratory and clinical data, primary and summary, that are generated with respect to the Study, including case report forms, safety information, informed consent forms and jedná o veškerou kompenzaci hrazenou podle této smlouvy, a že s výjimkou, jak se požaduje podle platné legislativy, zadavatel nenese žádnou odpovědnost za srážku ani úhradu jakýchkoli takovýchto daní za poskytovatele nebo jeho jménem.
Complete and Accurate Records. Institution and Investigator will maintain complete and accurate records of the status and progress of the Study as required by the Protocol. Institution will create and maintain complete and up-to-date medical records of Study subjects. Investigator will adhere to the accuracy of the Study results as required by the Applicable Law. 4.2 Kompletní a přesné záznamy. Nemocnice a zkoušející budou vést kompletní a přesné záznamy o stavu a postupu studie, jak vyžaduje protokol. Nemocnice vytvoří a bude vést kompletní a aktuální lékařské záznamy týkající se subjektů studie. Zkoušející bude dbát na přesnost výsledků studie v souladu s požadavky rozhodného zákona.
Complete and Accurate Records. Institution and Investigator will maintain complete and accurate records of the status and progress of the Study as required by the Protocol, with sufficient detail for use in reports to regulatory agencies. Institution poskytovat služby jakékoli farmaceutické, zdravotnické nebo biotechnologické společnosti ani o takovém zákazu neuvažuje. Zdravotnické zařízení získalo a bude zachovávat všechna oprávnění a povolení, která jsou zákonem předepsána pro zdravotnické zařízení a zkoušejícího, aby mohli provádět studii dle této smlouvy. 2.5
Complete and Accurate Records. Institution will keep complete and accurate records of the status and progress of the Clinical Trial as required by the Protocol and, in any event, with sufficient detail for use in reports to regulatory agencies.
Complete and Accurate Records. [Navy Collaborator] PI shall maintain complete and accurate records of the status and progress of the Cooperative Work and shall provide such information to [Non-Navy Collaborator] upon request. [Navy Collaborator] PI shall promptly complete, and allow [Non-Navy Collaborator] access to, [Non-Navy Collaborator]-supplied case report forms for all Study Patients. Upon [Non-Navy Collaborator]’s request, [Navy Collaborator] PI shall correct any case report form errors and/or omissions by promptly submitting [Non-Navy Collaborator]-supplied forms for resolving document discrepancies. At all times [Non-Navy Collaborator] shall remain the sole owner of the case report forms and document discrepancy resolution forms.
Complete and Accurate Records. Site shall, and shall cause PI and each Study Staff Member to, prepare, maintain and retain complete, current, accurate, organized and legible Study Data (as defined below) as required by the Protocol and in a manner acceptable for the collection of data for submission to, or review by, any national, supranational or other governmental body having legal authority with respect to the Drug (each, a “Regulatory Authority”), including the US Food and Drug Administration or any successor agency thereto (“FDA”), and in full compliance with the Protocol and Law. “Study Data” means all laboratory and clinical data, primary and summary, that are generated with respect to the Study, including case report forms, safety information, informed consent forms and PI’s study notebooks, excluding any original Subject medical records that are considered “Source Documents” (as defined by International Conference on Harmonization (ICH) Guidance E6 “Good Clinical Practice”). (b)
